{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.", "headline": {"main": "Biogen Reports Its Alzheimer\u2019s Drug Sharply Slowed Cognitive Decline", "print_headline": "Alzheimer\u2019s Drug Shows Promise in a Trial"}, "abstract": "Biogen Idec presents results of small Phase 1 trial of experimental Alzheimer's disease drug aducanumab in Nice, France, which suggest drug can sharply slow decline in mental function in patients; results, if replicated in larger studies, will revive hope for pharmaceutical approach to therapy that has long been elusive.", "print_page": "1", "word_count": "999", "_id": "550be9bc7988100e8ac09e49", "snippet": "The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/03/21/business/alzheimers-drug-trial-shows-cognitive-decline-sharply-slowed.html", "multimedia": [{"subtype": "wide", "url": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-articleLarge.jpg", "height": 453, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-articleLarge.jpg", "xlargeheight": "453"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Alzheimer's Disease", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Biogen Idec Inc", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Dementia", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Eli Lilly and Company", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Johnson & Johnson", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Roche Holding AG", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Nice (France)", "is_major": "N", "rank": "10", "name": "glocations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2015-03-21T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Upshot", "lead_paragraph": "It would be nice to imagine your children won\u2019t abuse any substances, but also unrealistic. The question is what to warn them against most strongly.", "headline": {"main": "Alcohol or Marijuana? A Pediatrician Faces the Question", "kicker": "The Upshot", "content_kicker": "The New Health Care"}, "abstract": null, "print_page": null, "word_count": "1384", "_id": "5506b7f6798810519b014257", "snippet": "It would be nice to imagine your children won\u2019t abuse any substances, but also unrealistic. The question is what to warn them against most strongly.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/03/17/upshot/alcohol-or-marijuana-a-pediatrician-faces-the-question.html", "multimedia": [{"subtype": "wide", "url": "images/2015/03/16/upshot/17UP-Pot/17UP-Pot-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/03/16/upshot/17UP-Pot/17UP-Pot-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/03/16/upshot/17UP-Pot/17UP-Pot-articleLarge.jpg", "height": 434, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/03/16/upshot/17UP-Pot/17UP-Pot-articleLarge.jpg", "xlargeheight": "434"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/03/16/upshot/17UP-Pot/17UP-Pot-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/03/16/upshot/17UP-Pot/17UP-Pot-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Marijuana", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Alcohol Abuse", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Drunken and Reckless Driving", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"firstname": "Aaron", "middlename": "E.", "lastname": "CARROLL", "rank": 1, "role": "reported", "organization": ""}], "original": "By AARON E. CARROLL"}, "document_type": "article", "pub_date": "2015-03-17T00:00:00Z", "section_name": "The Upshot"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Researchers cautioned, however, that the studies were small and meant to assess whether the drugs safely lowered cholesterol, not whether they staved off heart attacks.", "headline": {"main": "Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes", "print_headline": "Tests of Cholesterol Drugs Offer Hope of Reducing Heart Attacks and Strokes"}, "abstract": "Researchers report in New England Journal of Medicine that experimental cholesterol drugs may sharply reduce risk of heart attacks and strokes according to preliminary evidence.", "print_page": "3", "word_count": "981", "_id": "5505ab3a7988103a14492eaf", "snippet": "Researchers cautioned, however, that the studies were small and meant to assess whether the drugs safely lowered cholesterol, not whether they staved off heart attacks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/03/16/business/tests-of-cholesterol-drugs-offer-hope-of-reducing-heart-attacks-and-strokes.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Cholesterol", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Cleveland Clinic", "is_major": "N", "rank": "11", "name": "organizations"}, {"value": "Los Angeles (Calif)", "is_major": "N", "rank": "12", "name": "glocations"}, {"value": "San Diego (Calif)", "is_major": "N", "rank": "13", "name": "glocations"}, {"value": "New England Journal of Medicine", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Heart", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Stroke", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Amgen Inc", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Regeneron Pharmaceuticals Inc", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Sanofi SA", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "9", "name": "subject"}, {"value": "Nissen, Steven E", "is_major": "N", "rank": "10", "name": "persons"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2015-03-16T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 3, "offset": 0, "time": 48}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}